JENNIFER GOLDBERG: Open Payments
NPI 1235149774 · MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,508 in 322 payments from 24 companies in 2025. Trend: 2023 $2,844 · 2024 $3,696 · 2025 $4,508
Food & beverage: $4,106Consulting: $250Education: $152
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 70 | $719 |
| ABBVIE INC. | 46 | $525 |
| Botanix SB Inc | 30 | $429 |
| Novartis Pharmaceuticals Corporation | 15 | $264 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $256 |
| PFIZER INC. | 13 | $216 |
| Arcutis Biotherapeutics, Inc. | 17 | $209 |
| Incyte Corporation | 11 | $196 |
| UCB, Inc. | 16 | $195 |
| Lilly USA, LLC | 13 | $188 |
Products named: ILUMYA, SOFDRA, SKYRIZI, Neo-Synalar, DUPIXENT, Zoryve, OPZELURA, Bimzelx.
Industry payments across NJ — which companies pay providers there.
